Warfarin therapy does not increase bleeding in patients undergoing heart transplantation

Annals of Thoracic Surgery

Volumn 72, Issue 3, 2001, Pages 714-718

  Morris, Cullen D ^a,b   Vega, J David ^a,b   Levy, Jerrold H ^a,b   Buist, Nancy N ^a,b   Smith, Andrew L ^a,b   Despotis, George J ^a,b   Kanter, Kirk R ^a,b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FRESH FROZEN PLASMA; WARFARIN;

ADULT; ARTICLE; BLOOD TRANSFUSION; HEART TRANSPLANTATION; HUMAN; INTERNATIONAL STANDARD UNIT; MAJOR CLINICAL STUDY; POSTOPERATIVE HEMORRHAGE; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; STERNOTOMY; THROMBOCYTE TRANSFUSION;

ADULT; AGED; AGED, 80 AND OVER; ASPIRIN; BLOOD TRANSFUSION; CHEST TUBES; HEART TRANSPLANTATION; HUMANS; INTERNATIONAL NORMALIZED RATIO; LOGISTIC MODELS; MIDDLE AGED; MULTIVARIATE ANALYSIS; PLATELET COUNT; POSTOPERATIVE CARE; POSTOPERATIVE HEMORRHAGE; PREOPERATIVE CARE; RISK FACTORS; ROC CURVE; WARFARIN;

EID: 0034856645     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-4975(01)02828-4     Document Type: Article

References (23)

1. Stroke in patients with heart failure and reduced left ventricular ejection fraction
2. Incidence of thromboembolic events in congestive heart failure
3. Heart transplantation under coumarin therapy: Friend or foe?
4. The management of patients on chronic coumadin therapy undergoing subsequent surgical procedures
5. Warfarin pretreament does not lead to increased bleeding tendency during cardiac surgery
6. Aspirin- and coumadin-related bleeding after coronary-artery bypass graft surgery
7. Antithrombin deficiency in special clinical syndromes - Part II: Cardiovascular surgery
8. The platelet function defect of cardiopulmonary bypass
9. Bleeding after cardiopulmonary bypass
10. The influence of preoperative anticoagulation on heparin response during cardiopulmonary bypass
11. Early activation of hemostasis during cardiopulmonary bypass: Evidence for thrombin mediated hyperfibrinolysis
12. Heparin associated thrombocytopenia
13. Hirudin as anticoagulation for cardiopulmonary bypass: Importance of preoperative renal function
14. Sequential orthotopic heart transplantation in man
15. Platelet function during cardiac operation
16. Hematologic changes during and after cardiopulmonary bypass and their relationship to the bleeding time and nonsurgical blood loss
17. Predictors of excessive blood use after coronary artery bypass grafting
18. Defining the role of aprotinin in heart transplantation
19. Decreasing use of donated blood and reduction of bleeding after orthotopic heart transplantaion by use of aprotinin
20. Effect of aprotinin on transfusion requirements during repeat sternotomy for cardiac transplantation surgery
21. Factors associated with excessive postoperative blood loss and hemostatic transfusion requirements: A multivariate analysis in cardiac surgical patients
22. More effective suppression of hemostatic system activation in patients undergoing cardiac surgery by heparin dosing based on heparin blood concentrations rather than ACT
23. Coagulation and fibrinolysis system in aortic surgery under deep hypothermic circulatory arrest with aprotinin: The importance of adequate heparinization